RECRUITING

Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The overall goal of this study is to attempt to overcome the organizational barriers that impede prompt screening for at-risk sensory deficits in childhood cancer survivors (CCS). Using a cross sectional design study, collaborators in the Informatics Research branch of the Institute of Informatics at the Washington University School of Medicine will identify CCS at risk for sensory deficits based upon their therapy exposure to generate the highlighting patients at risk for sensory screening (HPARSS) document. The investigators will utilize the HPARSS that will link therapy related risks for sensory deficits to specific screening procedures prompting the primary oncology provider to implement screening, diagnostic testing, and therapy.

Official Title

Highlighting Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer Survivors

Quick Facts

Study Start:2023-08-02
Study Completion:2025-05-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05582551

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:7 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Patients with a diagnosis of pediatric cancer (diagnosis at \<18 years of age)
  2. * Treatment including chemotherapy and/or radiation therapy
  3. * Completion of all cancer therapy for at least 6 months and less than 2 years
  4. * Followed in the Division of Pediatric Hematology/Oncology Program at the Washington University School of Medicine
  5. * Current age between 7 and 17 years of age (age where all of the screening tests are both valid and have been successfully performed by our group)
  6. * English speaking
  1. * Undergoing active cancer treatment
  2. * Patient under the care of the Late Effects Program at St. Louis Children's Hospital
  3. * Received previous diagnostic testing or rehabilitative therapy for a secondary deficit eligible for screening.
  4. * Parents and/or patient illiteracy
  5. * No contact with treatment team in the past two years
  6. * In foster care or without a legal guardian

Contacts and Locations

Study Contact

Robert J Hayashi, M.D.
CONTACT
314-454-6018
hayashi_r@wustl.edu

Principal Investigator

Robert J Hayashi, M.D.
PRINCIPAL_INVESTIGATOR
Washington University School of Medicine

Study Locations (Sites)

St. Louis Children's Hospital - Washington University School of Medicine
Saint Louis, Missouri, 63110
United States

Collaborators and Investigators

Sponsor: Washington University School of Medicine

  • Robert J Hayashi, M.D., PRINCIPAL_INVESTIGATOR, Washington University School of Medicine

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-08-02
Study Completion Date2025-05-31

Study Record Updates

Study Start Date2023-08-02
Study Completion Date2025-05-31

Terms related to this study

Keywords Provided by Researchers

  • childhood cancer survivors
  • electronic medical record
  • sensory deficit screening
  • hearing loss
  • peripheral neuropathy
  • vestibular
  • vision

Additional Relevant MeSH Terms

  • Childhood Cancer